2023
DOI: 10.1016/j.neulet.2023.137532
|View full text |Cite
|
Sign up to set email alerts
|

Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches

Amirreza Gholami
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 218 publications
0
6
0
Order By: Relevance
“…Each APOE isoform appears to be differentially associated with amyloid β (Aβ)-related and Aβ-independent pathways involved in the course of AD (e.g., neuroinflammation, vascular function, blood-brain barrier function, and so on), ultimately altering the net risk of incident AD [34]. Previous research has specifically shown the crucial role of APOE in the metabolism of Aβ [37][38][39][40]. Isoform-dependent binding to Aβ regulates its production and clearance.…”
Section: The Multifaceted Role Of Apolipoprotein E In the Brainmentioning
confidence: 99%
“…Each APOE isoform appears to be differentially associated with amyloid β (Aβ)-related and Aβ-independent pathways involved in the course of AD (e.g., neuroinflammation, vascular function, blood-brain barrier function, and so on), ultimately altering the net risk of incident AD [34]. Previous research has specifically shown the crucial role of APOE in the metabolism of Aβ [37][38][39][40]. Isoform-dependent binding to Aβ regulates its production and clearance.…”
Section: The Multifaceted Role Of Apolipoprotein E In the Brainmentioning
confidence: 99%
“…According to the WHO, the number of people afflicted by AD will reach 66 million in 2030 and about 115 million by 2050. AD causes neuronal cell death, the development of neurofibrillary tangles composed of hyperphosphorylated tau protein and the formation of amyloid beta (Aβ) or senile plaques [14], as well as significant losses of cortically projecting cholinergic neurons and a reduction in the presynaptic markers of the cholinergic system. Low levels of acetylcholine in patients are associated with memory loss and a gradual learning decrease [15].…”
Section: Introductionmentioning
confidence: 99%
“…Alzheimer's disease (AD) is the most common neurodegenerative disease, whose classical phenotype is prominent long-term memory deficits that progress into dementia. Pathophysiological hallmarks of AD include extracellular amyloid-beta (Aβ) plaques, intracellular neurofibrillary tau tangles, and neuroinflammation (Gholami 2023 ; Tzioras et al 2023 ). Currently, AD remains incurable; however, treatments are available that can alleviate symptoms and enhance the quality of life for those affected (Scheltens et al 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, AD remains incurable; however, treatments are available that can alleviate symptoms and enhance the quality of life for those affected (Scheltens et al 2021 ). The elucidation of cellular and molecular mechanisms contributing to AD pathogenesis is crucial for identifying new therapeutic targets (Gholami 2023 ). Mechanisms such as oxidative damage and systemic inflammation may accelerate the progression of AD (Chen and Zhong 2014 ; Bello-Corral et al 2023 ).…”
Section: Introductionmentioning
confidence: 99%